Alpha 2.0
Login Register
» Articles » PMID: 26181277

JAMA Oncology Patient Page. Neoadjuvant Therapy

Overview
Journal JAMA Oncol
Publisher American Medical Association
Specialty Oncology
Date 2015 Jul 17
PMID 26181277
Citations 5
Authors
Howard Jack West
Jill Jin
Affiliations
Soon will be listed here.
Citing Articles

Liposarcoma: A Journey into a Rare Tumor's Epidemiology, Diagnosis, Pathophysiology, and Limitations of Current Therapies.

Jonczak E, Grossman J, Alessandrino F, Seldon Taswell C, Velez-Torres J, Trent J Cancers (Basel). 2024; 16(22).

PMID: 39594813 PMC: 11592651. DOI: 10.3390/cancers16223858.

Assessing the effectiveness of targeted agents in adjuvant therapy for patients with metastatic colorectal cancer undergoing surgical resection: a retrospective cohort study.

Su Y, Wu C, Chen Y, Su C, Chang Y, Hsieh M Ther Adv Med Oncol. 2024; 16:17588359241246427.

PMID: 38655393 PMC: 11036930. DOI: 10.1177/17588359241246427.

Agonistic Bivalent Human scFvs-Fcγ Fusion Antibodies to OX40 Ectodomain Enhance T Cell Activities against Cancer.

Mahasongkram K, Glab-Ampai K, Kaewchim K, Saenlom T, Chulanetra M, Sookrung N Vaccines (Basel). 2023; 11(12).

PMID: 38140230 PMC: 10747724. DOI: 10.3390/vaccines11121826.

Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis.

Davey M, Browne F, Miller N, Lowery A, Kerin M BJS Open. 2022; 6(3).

PMID: 35512244 PMC: 9071230. DOI: 10.1093/bjsopen/zrac028.

Exploring the Evolving Scope of Neoadjuvant Immunotherapy in NSCLC.

Roller J, Veeramachaneni N, Zhang J Cancers (Basel). 2022; 14(3).

PMID: 35159008 PMC: 8833612. DOI: 10.3390/cancers14030741.